IP Library › Granted Patent US 10,137,325
Granted Patent B2
US 10,137,325 · App. 14/667,231 · Granted Nov 27, 2018

System and method for deactivation and disposal of a pharmaceutical dosage form

Inventor: Shantha Sarangapani (Norwood, MA)
A62D3/38B01J27/053B01J31/2295B65D81/02B65D85/70A62D2101/20B01J2231/70B01J2531/842Y10T428/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,137,325
App. No.
14/667,231
Granted
Nov 27, 2018
Kind
B2
Abstract

A system and method are provided for deactivation and disposal of a pharmaceutical dosage form. The system and method employ an oxidant and an immobilizing agent placed in a container. The pharmaceutical dosage form is placed into the container, and water is added to the container. A rapid chemical deactivation of the active ingredient or ingredients in the pharmaceutical then occurs by a chemical oxidation process. Upon contact with the water, the immobilizing agent swells or expands in volume to form a gel or slurry, binding the other components in the container within the gel or slurry, where they remain after disposal. The system can be in the form of a kit, or can be scaled up for use by municipalities or institutions.

Claims (17)

1. A system for disposing of a pharmaceutical dosage form, the system comprising:

a container;

an oxidant selected from the group consisting of non-chlorine, stabilized peroxide compounds; stable chlorine-based oxidizing agents; and metal oxides, wherein the oxidant is contained in a first water soluble package;

a transition metal complex of a tetra-amido macrocyclic ligand as activating agent; and

an immobilizing agent;

wherein (i) the activating agent and the immobilizing agent are contained in second and third water soluble packages, or (ii) the activating agent and the immobilizing agent are provided as a mixture in a second water soluble package, or (iii) the activating agent is provided in a second water soluble package and the container comprises the immobilizing agent.

2. The system of claim 1 , wherein the stabilized peroxide compounds are selected from the group consisting of persulfate, permonosulfate, perborate, percarbonate, permanganate, stable organic peroxo compounds, and salts thereof.

3. The system of claim 1 , wherein the oxidant comprises magnesium oxide or calcium oxide.

4. The system of claim 1 , wherein the oxidant comprises one or more metal oxides in the form of particles ranging in size from nanometers to micrometers.

5. The system of claim 1 , wherein the immobilizing agent comprises a gelling agent or an encapsulant.

6. The system of claim 5 , wherein the encapsulant comprises one or more swellable clay minerals.

7. The system of claim 5 , wherein the encapsulant comprises montmorillonite or bentonite.

8. The system of claim 7 , wherein the bentonite comprises sodium bentonite.

9. The system of claim 1 , wherein the immobilizing agent comprises activated carbon.

10. The system of claim 1 , wherein the container includes a closure.

11. The system of claim 1 , wherein the container comprises a waterproof material.

12. The system of claim 1 , wherein the transition metal is Fe.

Continuity (2)
Provisional Application 61969473 · Mar 24, 2014
Related Publication 20150265867A1 · Sep 24, 2015